NCT00438256View on ClinicalTrials.gov

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Pancreatic Cancer

Interventions

PROCEDURE

Proton Beam Radiation

Given over different schedules and duration

DRUG

Capecitabine

Given orally starting on day one of radiation therapy for 2 weeks

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

02215

Massachusetts General Hospital, Boston

All Listed Sponsors

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00438256 - Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter